Recent Articles
The Scottish Medicines Consortium (SMC) ...
The SMC has confirmed NHS Scotland funding for MIRV (Elahere) in Scotland, offering eligible people with platinum-resistant ovarian cancer access to a new targeted treatment. Learn what the decision means for patients and their care.
Record-Breaking Touch of Teal Raises Ove...
Tour de Ovacome raises more than £7,000...
500km in 48 hours: The Big Weekend Team ...
Lisa
Ovacome Trustee Lisa shares her ovarian cancer story, sharing how she was diagnosed with mucinous ovarian cancer at the age of 41. In this story, Lisa recounts the challenges and changes caused by her diagnosis, as well as explaining why Ovacome is so important to her.
Christine
In this ovarian cancer story, Christine reflects on her diagnosis, the challenges she faced in getting answers, and how her experience led her into advocacy work. She also shares how advocacy helped her find her voice, challenge stigma, raise awareness and support others affected by ovarian cancer.
The 5th Annual Debbie Baldwin Gala Raise...
National Institute for Health and Care E...
Ovacome Runners Go the Distance at the 2...
Ovacome Community Raises Over £51,000 D...
Ella
Ella shares her story of being diagnosed with a rare form of ovarian cancer called mucinous ovarian cancer at age 28.
Ovacome Launches New Under 45's Hub
